Naoki Shimbara
- Molecular Biology top 2%
- Oncology top 5%
- Immunology top 5%
- Cell Biology top 2%
- Epidemiology top 5%
- Co-authors
- Keiji TanakaNobuyuki TanahashiAkira IchiharaTomohiro TamuraKlavs B. HendilMakoto TakashinaKinya AkiyamaMasashi Aki
- Topics
- Ubiquitin and proteasome pathways (34 papers)Peptidase Inhibition and Analysis (11 papers)Immunotherapy and Immune Responses (8 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Naoki Shimbara
41 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 2.6k
- Oncology 932
- Immunology 804
- Cell Biology 612
- Epidemiology 502
Countries citing papers authored by Naoki Shimbara
This map shows the geographic impact of Naoki Shimbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Shimbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Shimbara more than expected).
Fields of papers citing papers by Naoki Shimbara
This network shows the impact of papers produced by Naoki Shimbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Shimbara. The network helps show where Naoki Shimbara may publish in the future.
Co-authorship network of co-authors of Naoki Shimbara
This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Shimbara. A scholar is included among the top collaborators of Naoki Shimbara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Shimbara. Naoki Shimbara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 63 | |
| 3 | 103 | |
| 4 | 14 | |
| 5 | 25 | |
| 6 | 124 | |
| 7 | 44 | |
| 8 | 251 | |
| 9 | 39 | |
| 10 | 11 | |
| 11 | 28 | |
| 12 | 89 | |
| 13 | 54 | |
| 14 | 8 | |
| 15 | 334 | |
| 16 | 105 | |
| 17 | 23 | |
| 18 | 19 | |
| 19 | 29 | |
| 20 | 24 |
About Naoki Shimbara
Naoki Shimbara is a scholar working on Parasitology, Immunology and Molecular Biology, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (34 papers), Peptidase Inhibition and Analysis (11 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Immunology (804 citations), Molecular Biology (2.6k citations) and Cell Biology (612 citations). Naoki Shimbara has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Keiji Tanaka, Nobuyuki Tanahashi, Akira Ichihara, Tomohiro Tamura, Klavs B. Hendil, Makoto Takashina, Kinya Akiyama, Masashi Aki, George Demartino and Clive A. Slaughter. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.